株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界のヒトES細胞(hESC)研究市場

Human Embryonic Stem Cell (hESC) Research

発行 Global Industry Analysts, Inc. 商品コード 248880
出版日 ページ情報 英文 95 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=108.69円で換算しております。

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

世界のヒトES細胞(hESC)研究市場 Human Embryonic Stem Cell (hESC) Research
出版日: 2020年07月01日 ページ情報: 英文 95 Pages
概要

当レポートでは、世界のヒトES細胞(hESC)研究市場について調査し、市場の概要と今後の予測、地域別動向、および市場に参入する企業のプロファイルをまとめています。

第1章 イントロダクション、調査方法、製品定義

第2章 エグゼクティブサマリー

  • 業界概要
    • 幹細胞研究
    • ヒトES細胞(hESC)
    • ES細胞
    • 市場見通し
    • ES細胞研究開発のタイムライン
    • ヒトES細胞(hESC)研究の発展を阻害する問題
    • ヒトES細胞(hESC)の成長を確実にするための最善の発展経路に関する考察
    • 倫理的問題と技術的ハードルが市場を阻害 他
  • 法規制環境
    • 概要
    • 世界主要各国のヒトES細胞(hESC)に関する法規制
    • 知的財産
    • 欧州においてWARFが特許所得に失敗
    • 特許計画の多様性が課題
    • 特許に関する国際的分割がヒトES細胞(hESC)研究を阻害
  • ヒトES細胞(hESC)の用途と治験
    • 薬剤検査
    • 臨床応用
    • ヒトES細胞(hESC)由来の心筋細胞が心臓毒性の同定に寄与 他
  • 競合環境
    • 概要
    • hESCとiPSCに基づく薬剤および製品開発に携わる世界の主要企業
    • Astellas Institute of Regenerative Medicine
    • Asterias Biotherapeutics, Inc.
    • BD Biosciences
    • Cell Cure Neurosciences Ltd.
    • Cellular Dynamics International
    • GE Healthcare
    • MilliporeSigma
    • PerkinElmer, Inc.
    • Reliance Life Sciences Ltd.
    • Research & Diagnostics Systems, Inc.
    • SABiosciences Corp.
    • STEMCELL Technologies, Inc.
    • Stemina Biomarker Discovery, Inc.
    • タカラバイオ株式会社
    • TATAA Biocenter AB
    • Thermo Fisher Scientific, Inc
    • UK Stem Cell Bank
    • ViaCyte, Inc.
    • Vitrolife AB
  • 地域別市場概要
    • 米国
    • 欧州
    • アジア太平洋地域
  • 近年の業界活動
  • 世界市場見通し

第3章 市場

  • 米国
  • カナダ
  • 日本
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • その他の諸国
目次
Product Code: MCP-6831

Global Human Embryonic Stem Cell (hESC) Research Market to Reach US$1 Billion by the Year 2027

Amid the COVID-19 crisis, the global market for Human Embryonic Stem Cell (hESC) Research estimated at US$650.9 Million in the year 2020, is projected to reach a revised size of US$1 Billion by 2027, growing at a CAGR of 6.5% over the analysis period 2020-2027.Regenerative Medicine, one of the segments analyzed in the report, is projected to grow at a 6.6% CAGR to reach US$717.5 Million by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Stem Cell Biology Research segment is readjusted to a revised 7.4% CAGR for the next 7-year period. This segment currently accounts for a 16.3% share of the global Human Embryonic Stem Cell (hESC) Research market.

The U.S. Accounts for Over 29.5% of Global Market Size in 2020, While China is Forecast to Grow at a 6.1% CAGR for the Period of 2020-2027

The Human Embryonic Stem Cell (hESC) Research market in the U.S. is estimated at US$192.2 Million in the year 2020. The country currently accounts for a 29.53% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$177.3 Million in the year 2027 trailing a CAGR of 6.1% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.1% and 5.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.3% CAGR while Rest of European market (as defined in the study) will reach US$177.3 Million by the year 2027.

Tissue Engineering Segment Corners a 7.5% Share in 2020

In the global Tissue Engineering segment, USA, Canada, Japan, China and Europe will drive the 5.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$39.3 Million in the year 2020 will reach a projected size of US$55.9 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$116.4 Million by the year 2027.We bring years of research experience to this 15th edition of our report. The 95-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Astellas Institute of Regenerative Medicine
  • Asterias Biotherapeutics, Inc.
  • BD Biosciences
  • Cell Cure Neurosciences Ltd.
  • Cellular Dynamics International
  • GE Healthcare
  • PerkinElmer, Inc.
  • Reliance Life Sciences Ltd.
  • Research & Diagnostics Systems, Inc.
  • STEMCELL Technologies, Inc.
  • Stemina Biomarker Discovery, Inc.
  • Takara Bio, Inc.
  • TATAA Biocenter AB
  • Thermo Fischer Scientific Inc.
  • UK Stem Cell Bank
  • ViaCyte, Inc.

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Stem Cells Research: A Sunrise Sector in Biotechnology Arena
  • Human Embryonic Stem Cells - An Introduction
  • Embryonic Stem Cells - Sources and Cell Culture
  • Comparison on Adult and Embryonic Stem Cells
  • Advantages and Drawbacks of Various Stem Cells
  • Recent Market Activity
  • Human Embryonic Stem Cells - The Market Perspective
  • Timeline for Embryonic Stem Cell Research Activities: Major Events from 1963 through 2014
  • Teratomas - No Longer an Impediment to Stem Cell Therapy Development
  • Human Embryonic and Induced Pluripotent Stem Cell Research Trends
  • Human Embryonic Stem Cell Research: Key Statistical Highlights
  • Research Topics on hESC and hiPSC by Number of Papers Published: 2011-2013
  • Haploid Human Embryonic Stem Cell Line: The New Frontier
  • Human Induced Pluripotent Stem Cells Remains Best Alternative for hESC
  • Global Competitor Market Shares
  • Human Embryonic Stem Cell (hESC) Research Competitor Market Share Scenario Worldwide (in %): 2018 & 2029
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

  • Astellas Institute of Regenerative Medicine (US)
  • Asterias Biotherapeutics, Inc. (US)
  • BD Biosciences (US)
  • Cell Cure Neurosciences Ltd. (Israel)
  • Cellular Dynamics International (US)
  • GE Healthcare (UK)
  • MilliporeSigma (US)
  • PerkinElmer, Inc. (US)
  • Reliance Life Sciences Ltd. (India)
  • Research & Diagnostics Systems, Inc. (US)
  • SABiosciences Corp. (US)
  • STEMCELL Technologies, Inc. (Canada)
  • Stemina Biomarker Discovery, Inc. (US)
  • Takara Bio, Inc. (Japan)
  • TATAA Biocenter AB (Sweden)
  • Thermo Fisher Scientific, Inc. (US)
  • UK Stem Cell Bank (UK)
  • ViaCyte, Inc. (US)
  • Vitrolife AB (Sweden)

3. MARKET TRENDS & DRIVERS

  • Issues Hindering Development of hESC Research
  • Consideration of Best Translational Pathways Pivotal in Ensuring Growth Of hESCs
  • Ethical Issues and Technical Hurdles Bog Down hESC Research

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Human Embryonic Stem Cell (hESC) Research Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027
  • TABLE 2: Human Embryonic Stem Cell (hESC) Research Market Share Shift across Key Geographies Worldwide: 2020 VS 2027
  • TABLE 3: Regenerative Medicine (Application) Global Opportunity Assessment in US$ Thousand by Region/Country: 2020-2027
  • TABLE 4: Regenerative Medicine (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2020 VS 2027
  • TABLE 5: Stem Cell Biology Research (Application) Worldwide Sales in US$ Thousand by Region/Country: 2020-2027
  • TABLE 6: Stem Cell Biology Research (Application) Market Share Shift across Key Geographies: 2020 VS 2027
  • TABLE 7: Tissue Engineering (Application) Global Market Estimates & Forecasts in US$ Thousand by Region/Country: 2020-2027
  • TABLE 8: Tissue Engineering (Application) Market Share Breakdown by Region/Country: 2020 VS 2027
  • TABLE 9: Toxicology Testing (Application) Demand Potential Worldwide in US$ Thousand by Region/Country: 2020-2027
  • TABLE 10: Toxicology Testing (Application) Share Breakdown Review by Region/Country: 2020 VS 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Human Embryonic Stem Cell (hESC) Research Market Share (in %) by Company: 2018 & 2025
    • Market Analytics
    • TABLE 11: United States Human Embryonic Stem Cell (hESC) Research Latent Demand Forecasts in US$ Thousand by Application: 2020 to 2027
    • TABLE 12: Human Embryonic Stem Cell (hESC) Research Market Share Breakdown in the United States by Application: 2020 VS 2027
  • CANADA
    • TABLE 13: Canadian Human Embryonic Stem Cell (hESC) Research Market Quantitative Demand Analysis in US$ Thousand by Application: 2020 to 2027
    • TABLE 14: Canadian Human Embryonic Stem Cell (hESC) Research Market Share Analysis by Application: 2020 VS 2027
  • JAPAN
    • TABLE 15: Japanese Demand Estimates and Forecasts for Human Embryonic Stem Cell (hESC) Research in US$ Thousand by Application: 2020 to 2027
    • TABLE 16: Human Embryonic Stem Cell (hESC) Research Market Share Shift in Japan by Application: 2020 VS 2027
  • CHINA
    • TABLE 17: Chinese Demand for Human Embryonic Stem Cell (hESC) Research in US$ Thousand by Application: 2020 to 2027
    • TABLE 18: Chinese Human Embryonic Stem Cell (hESC) Research Market Share Breakdown by Application: 2020 VS 2027
  • EUROPE
    • Market Facts & Figures
    • European Human Embryonic Stem Cell (hESC) Research Market: Competitor Market Share Scenario (in %) for 2018 & 2025
    • Market Analytics
    • TABLE 19: European Human Embryonic Stem Cell (hESC) Research Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025
    • TABLE 20: European Human Embryonic Stem Cell (hESC) Research Market Share Shift by Region/Country: 2020 VS 2027
    • TABLE 21: European Human Embryonic Stem Cell (hESC) Research Addressable Market Opportunity in US$ Thousand by Application: 2020-2027
    • TABLE 22: European Human Embryonic Stem Cell (hESC) Research Market Share Analysis by Application: 2020 VS 2027
  • FRANCE
    • TABLE 23: Human Embryonic Stem Cell (hESC) Research Quantitative Demand Analysis in France in US$ Thousand by Application: 2020-2027
    • TABLE 24: French Human Embryonic Stem Cell (hESC) Research Market Share Analysis: A 7-Year Perspective by Application for 2020 and 2027
  • GERMANY
    • TABLE 25: Human Embryonic Stem Cell (hESC) Research Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by Application for the Period 2020-2027
    • TABLE 26: Human Embryonic Stem Cell (hESC) Research Market Share Distribution in Germany by Application: 2020 VS 2027
  • ITALY
    • TABLE 27: Italian Demand for Human Embryonic Stem Cell (hESC) Research in US$ Thousand by Application: 2020 to 2027
    • TABLE 28: Italian Human Embryonic Stem Cell (hESC) Research Market Share Breakdown by Application: 2020 VS 2027
  • UNITED KINGDOM
    • TABLE 29: United Kingdom Demand Estimates and Forecasts for Human Embryonic Stem Cell (hESC) Research in US$ Thousand by Application: 2020 to 2027
    • TABLE 30: Human Embryonic Stem Cell (hESC) Research Market Share Shift in the United Kingdom by Application: 2020 VS 2027
  • REST OF EUROPE
    • TABLE 31: Rest of Europe Human Embryonic Stem Cell (hESC) Research Addressable Market Opportunity in US$ Thousand by Application: 2020-2027
    • TABLE 32: Rest of Europe Human Embryonic Stem Cell (hESC) Research Market Share Analysis by Application: 2020 VS 2027
  • ASIA-PACIFIC
    • TABLE 33: Human Embryonic Stem Cell (hESC) Research Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by Application: 2020-2027
    • TABLE 34: Asia-Pacific Human Embryonic Stem Cell (hESC) Research Market Share Analysis: A 7-Year Perspective by Application for 2020 and 2027
  • REST OF WORLD
    • TABLE 35: Rest of World Human Embryonic Stem Cell (hESC) Research Market Quantitative Demand Analysis in US$ Thousand by Application: 2020 to 2027
    • TABLE 36: Rest of World Human Embryonic Stem Cell (hESC) Research Market Share Analysis by Application: 2020 VS 2027

IV. COMPETITION

  • Total Companies Profiled: 25